GLP-1 coverage in Virginia

Documented Medicaid fee-for-service status and insurance-mandate activity — not a decision for your member ID.

Sources last checked October 29, 2026

Spot an error? Report a correction

Medicaid (obesity / weight-loss)

Virginia Medicaid
Covers (with prior auth)

KFF, "Medicaid Coverage of and Spending on GLP-1s", January 2026

This is the KFF January 2026 fee-for-service survey row for Virginia. Managed-care plans in the same state can differ. GLP-1s prescribed for type 2 diabetes are covered by every state Medicaid program regardless of this row.

Virginia Medicaid requires a BMI of 40, or 35 with two chronic conditions, plus failed lifestyle and non-GLP-1 treatment before approving GLP-1s for weight loss.

DMAS requires a BMI of at least 40, or a BMI of at least 35 with two or more chronic conditions, before approving GLP-1 drugs for weight loss.

Source: Virginia DMAS Medicaid Bulletin: Upcoming Changes to Service Authorization Criteria for Weight-Loss Drugs, 2023-06-23

Patients must try and fail comprehensive lifestyle interventions, and must try and fail a non-GLP-1 weight loss drug in the previous six months before a GLP-1 is approved.

Source: Virginia DMAS Medicaid Bulletin: Upcoming Changes to Service Authorization Criteria for Weight-Loss Drugs, 2023-06-23

The bulletin applies to providers and managed care organizations in Virginia Medicaid and FAMIS. Active authorizations approved under the prior criteria were honored, and future requests and reauthorizations follow the updated criteria.

Source: Virginia DMAS Medicaid Bulletin: Upcoming Changes to Service Authorization Criteria for Weight-Loss Drugs, 2023-06-23

Stateline reports that Virginia is among the states covering GLP-1s for obesity in 2026. The DMAS bulletin is dated June 2023, and we did not find a later Virginia criteria document, so check DMAS for updates.

Source: Stateline (States Newsroom), as republished by The Lund Report, 2026-04-30

Diabetes

The bulletin covers weight-loss criteria and does not state diabetes GLP-1 rules. We have not verified Virginia's criteria for diabetes GLP-1s such as Ozempic and Mounjaro.

Source: Virginia DMAS Medicaid Bulletin: Upcoming Changes to Service Authorization Criteria for Weight-Loss Drugs, 2023-06-23

State insurance-mandate activity

Virginia mandate
Enacted (see what it actually does)

Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025

Regulatory amendment covers GLP-1s under Medicaid with prior authorization and eligibility conditions

Also: HealthInsurance.org state coverage tracker (general), 2026. A headline about a bill is not the same as coverage on your card.

What to do with this

No state page knows your contract.

Medicaid survey rows and mandate bills are not a prior-authorization approval. Call the number on your ID card and ask whether the drug is covered for your diagnosis.

Full 5-step checklist →

Related: All state pages · Medicaid by state · State laws · Cash-pay options